The merger was valued at $3.26 billion when it was pitched by Optum earlier in June. The agreement calls for the acquisition of Amedisys’ outstanding common stock in an all-cash transaction for $101 per share, according to a June 26 news release from Amedisys.
According to the release, the merger “unites two organizations dedicated to providing compassionate, value-based comprehensive care to patients and their families.”
Amedisys has about 18,000 employees in 522 care centers across 37 states and Washington, D.C.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
